David J F Smith
Overview
Explore the profile of David J F Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Z, Smith D, Yazbeck L, Saunders P, Smith J, Maher T, et al.
Am J Respir Crit Care Med
. 2024 Feb;
209(9):1165-1167.
PMID: 38301238
No abstract available.
2.
Smith D, Meghji J, Moonim M, Ross C, Viola P, Wickremasinghe M, et al.
Respirol Case Rep
. 2023 Oct;
11(11):e01231.
PMID: 37840600
Here we describe three cases of sarcoidosis which were diagnosed following COVID infection. Treating clinicians should consider post-COVID-19 sarcoidosis in their differential, as it represents a potentially treatable cause of...
3.
Barnett J, Maher T, Quint J, Adamson A, Wu Z, Smith D, et al.
Am J Respir Crit Care Med
. 2023 Sep;
208(9):975-982.
PMID: 37672028
Identifying patients with pulmonary fibrosis (PF) at risk of progression can guide management. To explore the utility of combining baseline BAL and computed tomography (CT) in differentiating progressive and nonprogressive...
4.
Singh S, Baldwin M, Daynes E, Evans R, Greening N, Gisli Jenkins R, et al.
Lancet Respir Med
. 2023 May;
11(8):709-725.
PMID: 37216955
Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is unknown, more than a third of patients with COVID-19 develop symptoms that persist for more than 3...
5.
Saunders P, Wu Z, Fahy W, Stewart I, Saini G, Smith D, et al.
Ann Am Thorac Soc
. 2023 May;
20(9):1267-1273.
PMID: 37159951
Cough is a commonly reported symptom in idiopathic pulmonary fibrosis (IPF) that negatively impacts patient-reported quality of life (QoL). However, both the burden of cough at diagnosis and the behavior...
6.
Smith D, Gisli Jenkins R
Respirology
. 2023 Apr;
28(7):627-635.
PMID: 37121779
Novel genetic associations for idiopathic pulmonary fibrosis (IPF) risk have been identified. Common genetic variants associated with IPF are also associated with chronic hypersensitivity pneumonitis. The characterization of underlying mechanisms,...
7.
Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles
Asghar S, Monkley S, Smith D, Hewitt R, Grime K, Murray L, et al.
Respir Res
. 2023 Feb;
24(1):51.
PMID: 36788603
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that affects 3 million people worldwide. Senescence and small extracellular vesicles (sEVs) have been implicated in the pathogenesis of IPF,...
8.
Stewart I, Jacob J, George P, Molyneaux P, Porter J, Allen R, et al.
Am J Respir Crit Care Med
. 2022 Dec;
207(6):693-703.
PMID: 36457159
Shared symptoms and genetic architecture between coronavirus disease (COVID-19) and lung fibrosis suggest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to progressive lung damage. The UK Interstitial...
9.
Simpson T, Barratt S, Beirne P, Chaudhuri N, Crawshaw A, Crowley L, et al.
Eur Respir J
. 2021 Mar;
58(1).
PMID: 33678609
No abstract available.
10.
Khor Y, Smith D, Johannson K, Renzoni E
Curr Opin Pulm Med
. 2020 Jul;
26(5):464-469.
PMID: 32657832
Purpose Of Review: Supplemental oxygen therapy is prescribed for management of hypoxaemia in patients with interstitial lung disease (ILD). This review summarizes current evidence and implications of the use of...